David Taieb

264, Rue Saint Pierre
Marseille, 13385, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 298 publications

What parathyroid imaging is required for hyperparathyroidism?

What parathyroid imaging is required for hyperparathyroidism?

Journal: Journal of visceral surgery
Published: August 17, 2026

Correction: Deciphering 18F-DOPA uptake in SDH-related head and neck paragangliomas: a radiomics approach.

Correction: Deciphering 18F-DOPA uptake in SDH-related head and neck paragangliomas: a radiomics approach.

Journal: Journal of endocrinological investigation
Published: July 16, 2026

Decoding Pheochromocytomas and Paragangliomas PET Phenotypes: Looking Beyond Genotype.

Decoding Pheochromocytomas and Paragangliomas PET Phenotypes: Looking Beyond Genotype.

Journal: Endocrine-related cancer
Published: July 03, 2026

Correction: A Randomized clinical trial evaluating the impact on survival and quality of life of 177Lutetium[Lu]-edotreotide versus everolimus in patients with neuroendocrine tumors of the lung and thymus: the LEVEL study (GETNE T-2217).

Correction: A Randomized clinical trial evaluating the impact on survival and quality of life of 177Lutetium[Lu]-edotreotide versus everolimus in patients with neuroendocrine tumors of the lung and thymus: the LEVEL study (GETNE T-2217).

Journal: BMC cancer
Published: June 13, 2026

Genotype-location interaction defines the SSTR-PET phenotype in paragangliomas and pheochromocytomas.

Genotype-location interaction defines the SSTR-PET phenotype in paragangliomas and pheochromocytomas.

Journal: European journal of nuclear medicine and molecular imaging
Published: June 01, 2026

Pheochromocytomas and Paragangliomas.

Pheochromocytomas and Paragangliomas.

Journal: Endocrinology and metabolism clinics of North America
Published: May 01, 2026

Prospective study on the [18F]FDOPA PET/CT role in the management of medullary thyroid cancer patients with high residual calcitonin level after surgery.

Prospective study on the [18F]FDOPA PET/CT role in the management of medullary thyroid cancer patients with high residual calcitonin level after surgery.

Journal: European journal of nuclear medicine and molecular imaging
Published: February 06, 2026

Radiopharmaceutical Therapy Meets Radiobiology: Implications for Trial Design and DNA Repair Inhibitor Combinations.

Radiopharmaceutical Therapy Meets Radiobiology: Implications for Trial Design and DNA Repair Inhibitor Combinations.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: January 30, 2026

Molecular imaging and radioligand therapies in pheochromocytomas and paragangliomas.

Molecular imaging and radioligand therapies in pheochromocytomas and paragangliomas.

Journal: Endocrine-related cancer
Published: January 28, 2026

Molecular Imaging and Radioligand Therapies in Pheochromocytomas and Paragangliomas.

Molecular Imaging and Radioligand Therapies in Pheochromocytomas and Paragangliomas.

Journal: Endocrine-related cancer
Published: January 28, 2026

Role of 18F-PSMA PET/MRI in Prostate Cancer Recurrence After Prostatectomy.

Role of 18F-PSMA PET/MRI in Prostate Cancer Recurrence After Prostatectomy.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: January 20, 2026

Diffuse alveolar hemorrhage in antiphospholipid syndrome: Clinical presentation and prognosis.

Diffuse alveolar hemorrhage in antiphospholipid syndrome: Clinical presentation and prognosis.

Journal: Respiratory medicine
Published: January 07, 2026
Showing 1-12 of 298

Last Updated: 09/26/2026